首页> 外文OA文献 >Statistical Inference for Costs and Incremental Cost-Effectiveness Ratios with Censored Data
【2h】

Statistical Inference for Costs and Incremental Cost-Effectiveness Ratios with Censored Data

机译:带有删失数据的成本和增量成本效益比的统计推断

摘要

Cost-effectiveness analysis is widely conducted in the economic evaluation of new treatment options. In many clinical and observational studies of costs, data are often censored. Censoring brings challenges to both medical cost estimation and cost-effectiveness analysis. Although methods have been proposed for estimating the mean costs with censored data, they are often derived from theory and it is not always easy to understand how these methods work. We provide an alternative method for estimating the mean cost more efficiently based on a replace-from-the-right algorithm, and show that this estimator is equivalent to an existing estimator based on the inverse probability weighting principle and semiparametric efficiency theory. Therefore, we provide an intuitive explanation to a theoretically derived mean cost estimator.In many applications, it is also important to estimate the survival function of costs. We propose a generalized redistribute-to-the right algorithm for estimating the survival function of costs with censored data, and show that it is equivalent to a simple weighted survival estimator of costs based on inverse probability weighting techniques. Motivated by this redistribute-to-the-right principle, we also develop a more efficient survival estimator for costs, which has the desirable property of being monotone, and more efficient, although not always consistent. We conduct simulation to compare our method with some existing survival estimators for costs, and find the bias seems quite small. Thus, it may be considered as a candidate for survival estimator for costs in a real setting when the censoring is heavy and cost history information is available.Finally, we consider one special situation in conducting cost-effectiveness analysis, when the terminating events for survival time and costs are different. Traditional methods for statistical inference cannot deal with such data. We propose a new method for deriving the confidence interval for the incremental cost-effectiveness ratio under this situation, based on counting process and the general theory for missing data process. The simulation studies show that our method performs very well for some practical settings. Our proposed method has a great potential of being applied to a real setting when different terminating events exist for survival time and costs.
机译:在对新治疗方案进行经济评估时,广泛进行了成本效益分析。在许多成本的临床和观察性研究中,通常会检查数据。审查给医疗成本估算和成本效益分析带来了挑战。尽管已提出了使用删失数据估算平均成本的方法,但它们通常是从理论中得出的,并不总是很容易理解这些方法的工作原理。我们提供了一种基于权利替代算法更有效地估算平均成本的替代方法,并表明该估算器等效于基于逆概率加权原理和半参数效率理论的现有估算器。因此,我们为理论推导的平均成本估算器提供了直观的解释。在许多应用中,估算成本的生存函数也很重要。我们提出了一种广义右分配算法,用于估计带有删失数据的成本的生存函数,并表明它等效于基于逆概率加权技术的简单的成本加权生存估计器。受此权利分配原则的激励,我们还开发了一种更有效的成本生存估计器,该估计器具有单调的期望属性,并且效率更高,尽管并不总是一致的。我们进行了仿真,以将我们的方法与一些现有的生存估计器进行成本比较,发现偏差似乎很小。因此,当审查工作繁重且可获得成本历史信息时,它可能被视为真实环境中成本生存估计的候选者。最后,当生存终止事件发生时,我们在进行成本效益分析时会考虑一种特殊情况。时间和成本是不同的。传统的统计推断方法无法处理此类数据。我们基于计数过程和丢失数据过程的一般理论,提出了一种在这种情况下推导增量成本效益比置信区间的新方法。仿真研究表明,我们的方法在某些实际设置中效果很好。当存在不同的终止事件以延长生存时间和降低成本时,我们提出的方法具有很大的潜力可用于实际环境。

著录项

  • 作者

    Chen Shuai;

  • 作者单位
  • 年度 2012
  • 总页数
  • 原文格式 PDF
  • 正文语种 en_US
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号